BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

904 related articles for article (PubMed ID: 18191335)

  • 21. 3D CT-based volumetric dose assessment of 2D plans using GEC-ESTRO guidelines for cervical cancer brachytherapy.
    Gao M; Albuquerque K; Chi A; Rusu I
    Brachytherapy; 2010; 9(1):55-60. PubMed ID: 19853536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3D inverse treatment planning for the tandem and ovoid applicator in cervical cancer.
    Dewitt KD; Hsu IC; Speight J; Weinberg VK; Lessard E; Pouliot J
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1270-4. PubMed ID: 16253782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results.
    Kirisits C; Lang S; Dimopoulos J; Berger D; Georg D; Pötter R
    Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):624-30. PubMed ID: 16690444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical use of the Utrecht applicator for combined intracavitary/interstitial brachytherapy treatment in locally advanced cervical cancer.
    Nomden CN; de Leeuw AA; Moerland MA; Roesink JM; Tersteeg RJ; Jürgenliemk-Schulz IM
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1424-30. PubMed ID: 21669505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: report from Image-Guided Brachytherapy Working Group.
    Nag S; Cardenes H; Chang S; Das IJ; Erickson B; Ibbott GS; Lowenstein J; Roll J; Thomadsen B; Varia M;
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1160-72. PubMed ID: 15519788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of dose-volume parameters, endoscopic and clinical rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI-based brachytherapy.
    Georg P; Kirisits C; Goldner G; Dörr W; Hammer J; Pötzi R; Berger D; Dimopoulos J; Georg D; Pötter R
    Radiother Oncol; 2009 May; 91(2):173-80. PubMed ID: 19243846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Feasibility of applying a single treatment plan for both fractions in PDR image guided brachytherapy in cervix cancer.
    Mohamed S; Nielsen SK; Fokdal LU; Pedersen EM; Lindegaard JC; Tanderup K
    Radiother Oncol; 2013 Apr; 107(1):32-8. PubMed ID: 23333020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of alternative biological modelling parameters (α/β and half time of repair T ½ ) on reported EQD2 values in the treatment of advanced cervical cancer.
    De Leeuw AA; Van de Kamer JB; Moerland MA; Philippens ME; Jürgenliemk-Schulz IM
    Radiother Oncol; 2011 Nov; 101(2):337-42. PubMed ID: 21742393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-dose-rate interstitial brachytherapy for gynecologic malignancies.
    Beriwal S; Bhatnagar A; Heron DE; Selvaraj R; Mogus R; Kim H; Gerszten K; Kelley J; Edwards RP
    Brachytherapy; 2006; 5(4):218-22. PubMed ID: 17118313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical comparison of two linear-quadratic model-based isoeffect fractionation schemes of high-dose-rate intracavitary brachytherapy for cervical cancer.
    Wang CJ; Huang EY; Sun LM; Chen HC; Fang FM; Hsu HC; Changchien CC; Leung SW
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):179-89. PubMed ID: 15093915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late effects after radiotherapy for locally advanced cervical cancer: comparison of two brachytherapy schedules and effect of dose delivered weekly.
    Hellebust TP; Kristensen GB; Olsen DR
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):713-8. PubMed ID: 19427739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Variation of treatment planning parameters (D90 HR-CTV, D 2cc for OAR) for cervical cancer tandem ring brachytherapy in a multicentre setting: comparison of standard planning and 3D image guided optimisation based on a joint protocol for dose-volume constraints.
    Jürgenliemk-Schulz IM; Lang S; Tanderup K; de Leeuw A; Kirisits C; Lindegaard J; Petric P; Hudej R; Pötter R;
    Radiother Oncol; 2010 Mar; 94(3):339-45. PubMed ID: 19944471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inverse planning simulated annealing for magnetic resonance imaging-based intracavitary high-dose-rate brachytherapy for cervical cancer.
    Kubicky CD; Yeh BM; Lessard E; Joe BN; Speight JL; Pouliot J; Hsu IC
    Brachytherapy; 2008; 7(3):242-7. PubMed ID: 18468959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Single versus customized treatment planning for image-guided high-dose-rate brachytherapy for cervical cancer: dosimetric comparison and predicting factor for organs at risk overdose with single plan approach.
    Chi A; Gao M; Sinacore J; Nguyen NP; Vali F; Albuquerque K
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):309-14. PubMed ID: 19540070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intensity modulated proton beam radiation for brachytherapy in patients with cervical carcinoma.
    Clivio A; Kluge A; Cozzi L; Köhler C; Neumann O; Vanetti E; Wlodarczyk W; Marnitz S
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):897-903. PubMed ID: 24119834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cervical brachytherapy utilizing ring applicator: comparison of standard and conformal loading.
    Brooks S; Bownes P; Lowe G; Bryant L; Hoskin PJ
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):934-9. PubMed ID: 16199322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of 3D image-based PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study.
    Charra-Brunaud C; Harter V; Delannes M; Haie-Meder C; Quetin P; Kerr C; Castelain B; Thomas L; Peiffert D
    Radiother Oncol; 2012 Jun; 103(3):305-13. PubMed ID: 22633469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer.
    Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K
    Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of locally advanced vaginal cancer with radiochemotherapy and magnetic resonance image-guided adaptive brachytherapy: dose-volume parameters and first clinical results.
    Dimopoulos JC; Schmid MP; Fidarova E; Berger D; Kirisits C; Pötter R
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1880-8. PubMed ID: 21868174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Image-guided cervix high-dose-rate brachytherapy treatment planning: does custom computed tomography planning for each insertion provide better conformal avoidance of organs at risk?
    Davidson MT; Yuen J; D'Souza DP; Batchelar DL
    Brachytherapy; 2008; 7(1):37-42. PubMed ID: 18299111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.